{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:36:27Z","timestamp":1792254987888,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.jaut.2009.09.010","type":"journal-article","created":{"date-parts":[[2009,10,28]],"date-time":"2009-10-28T04:22:43Z","timestamp":1256703763000},"page":"178-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis"],"prefix":"10.1016","volume":"33","author":[{"given":"V.","family":"Barak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Selmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schlesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Agmon-Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Kalickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2009.09.010_bib1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaut.2009.09.010_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1385\/CRIAI:28:2:073","article-title":"The enigma of primary biliary cirrhosis","volume":"28","author":"Selmi","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaut.2009.09.010_bib3","first-page":"13","article-title":"The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases \u2013 2008","volume":"10","author":"Shoenfeld","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.jaut.2009.09.010_bib4","first-page":"3","article-title":"The mosaic of autoimmunity: genetic factors involved in autoimmune diseases \u2013 2008","volume":"10","author":"Shoenfeld","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.jaut.2009.09.010_bib5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/BF01296928","article-title":"Primary biliary cirrhosis associated with features of systemic lupus erythematosus","volume":"27","author":"Iliffe","year":"1982","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaut.2009.09.010_bib6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jhep.2008.06.006","article-title":"The unfinished business of primary biliary cirrhosis","volume":"49","author":"Selmi","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jaut.2009.09.010_bib7","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2009.09.010_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/hep.1840080128","article-title":"Primary biliary cirrhosis and mitochondrial autoantigens \u2013 insights from molecular biology","volume":"8","author":"Gershwin","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2009.09.010_bib9","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.4049\/jimmunol.153.6.2750","article-title":"Primary biliary cirrhosis. High proportions of B cells in blood and liver tissue produce anti-mitochondrial antibodies of several Ig classes","volume":"153","author":"Bjorkland","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2009.09.010_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1034\/j.1600-0528.2002.017402.x","article-title":"Primary biliary cirrhosis: an orchestrated immune response against epithelial cells","volume":"174","author":"Gershwin","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaut.2009.09.010_bib11","first-page":"1106","article-title":"Blood and liver-infiltrating lymphocytes in primary biliary cirrhosis: increase in activated T and natural killer cells and recruitment of primed memory T cells","volume":"13","author":"Bjorkland","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2009.09.010_bib12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.1840120219","article-title":"Analysis of hepatic T lymphocyte and immunoglobulin deposits in patients with primary biliary cirrhosis","volume":"12","author":"Krams","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2009.09.010_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF02918614","article-title":"Complement profile in primary biliary cirrhosis","volume":"11","author":"Schlesinger","year":"1992","journal-title":"Immunol Res"},{"key":"10.1016\/j.jaut.2009.09.010_bib14","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0016-5085(92)91122-K","article-title":"Serum levels of cytokines in chronic liver diseases","volume":"103","author":"Tilg","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2009.09.010_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cyto.2005.04.007","article-title":"Soluble ICAM-1: a marker of vascular inflammation and lifestyle","volume":"31","author":"Witkowska","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.jaut.2009.09.010_bib16","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.510250507","article-title":"Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2009.09.010_bib17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/10428199209049799","article-title":"Serum soluble interleukin-2 receptor levels are associated with clinical disease status and histopathological grade in non-Hodgkin's lymphoma and chronic lymphocytic leukemia","volume":"7","author":"Barak","year":"1992","journal-title":"Leuk Lymphoma"},{"issue":"Suppl. 1","key":"10.1016\/j.jaut.2009.09.010_bib18","first-page":"33","article-title":"Serum interleukin 1 beta levels as a marker in hairy cell leukemia: correlation with disease status and sIL-2R levels","volume":"14","author":"Barak","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaut.2009.09.010_bib19","doi-asserted-by":"crossref","DOI":"10.1007\/s00281-009-0155-6","article-title":"Liver architecture, cell function, and disease","author":"Ishibashi","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jaut.2009.09.010_bib20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/j.gastro.2004.11.005","article-title":"Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis","volume":"128","author":"Kikuchi","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2009.09.010_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0896-8411(05)80014-9","article-title":"Identification of the platelet glycoprotein IIb\/IIIa complex as a target antigen in primary biliary cirrhosis-associated autoimmune thrombocytopenia. Evidence that platelet-reactive autoantibodies can also bind to the mitochondrial antigen M2","volume":"3","author":"Panzer","year":"1990","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2009.09.010_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaut.2007.06.001","article-title":"Influence of interleukin-2 deficiency on the generation of autoimmune B cells","volume":"29","author":"Wrenshall","year":"2007","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2009.09.010_bib23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaut.2009.01.002","article-title":"Variation in the IL7RA and IL2RA genes in German multiple sclerosis patients","volume":"32","author":"Akkad","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2009.09.010_bib24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/MEG.0b013e3282f43aae","article-title":"Increased soluble IL-2 receptor levels during interferon and ribavirin treatment are associated with a good response in genotype 2a\/2b patients with chronic hepatitis C","volume":"20","author":"Abe","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2009.09.010_bib25","first-page":"19","article-title":"Cytokine receptors in diseases","volume":"32","author":"Barak","year":"1995","journal-title":"Israel J Med Sci"},{"key":"10.1016\/j.jaut.2009.09.010_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2008.03.002","article-title":"The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2)","volume":"31","author":"Lan","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2009.09.010_bib27","first-page":"465","article-title":"Serum interleukin-2 and tumor necrosis factor-alpha in primary biliary cirrhosis: decrease by colchicine and relationship to HLA-DR4","volume":"87","author":"Miller","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2009.09.010_bib28","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.20859","article-title":"Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis","volume":"42","author":"Mao","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2009.09.010_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/156652409787314525","article-title":"Innate immunity and primary biliary cirrhosis","volume":"9","author":"Selmi","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.jaut.2009.09.010_bib30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-2249.2000.01356.x","article-title":"Serum interferon-gamma-inducing factor\/IL-18 levels in primary biliary cirrhosis","volume":"122","author":"Yamano","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2009.09.010_bib31","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7326\/0003-4819-110-6-446","article-title":"Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration","volume":"110","author":"Kahaleh","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaut.2009.09.010_bib32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaut.2007.02.013","article-title":"Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process?","volume":"28","author":"Cavazzana","year":"2007","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2009.09.010_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2008.03.006","article-title":"MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner","volume":"31","author":"Hoshino","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2009.09.010_bib34","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/eji.1830190605","article-title":"Interleukin 6 stimulates synthesis of complement proteins factor B and C3 in human skin fibroblasts","volume":"19","author":"Katz","year":"1989","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaut.2009.09.010_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-immunol-082708-100732","article-title":"Translating molecular insights in autoimmunity into effective therapy","volume":"27","author":"Feldmann","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaut.2009.09.010_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jbspin.2007.03.003","article-title":"Effect of tumor necrosis factor alpha antagonists in a patient with rheumatoid arthritis and primary biliary cirrhosis","volume":"75","author":"Spadaro","year":"2008","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.jaut.2009.09.010_bib37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.mehy.2003.11.044","article-title":"Bupropion for fatigue and as a tumor necrosis factor-alpha lowering agent in primary biliary cirrhosis","volume":"64","author":"Altschuler","year":"2005","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jaut.2009.09.010_bib38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00042737-200012040-00016","article-title":"Serum interferon gamma in primary biliary cirrhosis: effect of ursodeoxycholic acid and prednisone therapy alone and in combination","volume":"12","author":"Fracchia","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2009.09.010_bib39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1440-1746.2002.02672.x","article-title":"Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis","volume":"17","author":"Neuman","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2009.09.010_bib40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2007.11.001","article-title":"Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?","volume":"30","author":"Binard","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2009.09.010_bib41","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jaut.2007.10.001","article-title":"Interleukin-27 suppresses experimental autoimmune encephalomyelitis during bone marrow stromal cell treatment","volume":"30","author":"Wang","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2009.09.010_bib42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaut.2007.07.004","article-title":"Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion","volume":"29","author":"Liu","year":"2007","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2009.09.010_bib43","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2007.07.001","article-title":"Th1-type immune responses by Toll-like receptor 4 signaling are required for the development of myocarditis in mice with BCG-induced myocarditis","volume":"29","author":"Nishikubo","year":"2007","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2009.09.010_bib44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaut.2008.04.006","article-title":"The development of targeted therapies in rheumatoid arthritis","volume":"31","author":"Vital","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2009.09.010_bib45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00535-007-2019-y","article-title":"Primary biliary cirrhosis: what we know and what we want to know about human PBC and spontaneous PBC mouse models","volume":"42","author":"Ueno","year":"2007","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jaut.2009.09.010_bib46","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaut.2008.04.004","article-title":"A tribute to an outstanding immunologist \u2013 Ian Reay Mackay","volume":"31","author":"Whittingham","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2009.09.010_bib47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaut.2007.12.006","article-title":"Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara","volume":"30","author":"Gershwin","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2009.09.010_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2007.11.015","article-title":"Autoimmunity: from the mosaic to the kaleidoscope","volume":"30","author":"Blank","year":"2008","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2009.09.010_bib49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jaut.2008.08.004","article-title":"The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity","volume":"31","author":"Shoenfeld","year":"2008","journal-title":"J\u00a0Autoimmmun"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841109001243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841109001243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:01:49Z","timestamp":1760256109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841109001243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":49,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0896841109001243"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2009.09.010","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2009.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}